BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
To decrease bowel cancer incidence and improve survival, we need to understand the mechanisms that drive tumorigenesis. Recently, B-cell lymphoma 3 (BCL-3; a key regulator of NF-κB signalling) has been recognised as an important oncogenic player in solid tumours. Although reported to be overexpresse...
Main Authors: | Danny N. Legge, Alex P. Shephard, Tracey J. Collard, Alexander Greenhough, Adam C. Chambers, Richard W. Clarkson, Christos Paraskeva, Ann C. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2019-03-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/12/3/dmm037697 |
Similar Items
-
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age
by: Gillian Seaton, et al.
Published: (2024-01-01) -
RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency
by: Alexis L. Santana, et al.
Published: (2017-02-01) -
NF-κB in Cancer Immunity: Friend or Foe?
by: Guilhem Lalle, et al.
Published: (2021-02-01) -
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
by: Demetra H. Hufnagel, et al.
Published: (2020-09-01) -
Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells
by: Mohapatra Shyam S, et al.
Published: (2002-07-01)